U.S. flag

An official website of the United States government

NM_001110792.2(MECP2):c.1193_1224del (p.Leu398fs) AND Rett syndrome

Germline classification:
Pathogenic (4 submissions)
Last evaluated:
Mar 8, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000168702.6

Allele description [Variation Report for NM_001110792.2(MECP2):c.1193_1224del (p.Leu398fs)]

NM_001110792.2(MECP2):c.1193_1224del (p.Leu398fs)

Gene:
MECP2:methyl-CpG binding protein 2 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_001110792.2(MECP2):c.1193_1224del (p.Leu398fs)
Other names:
NM_001110792.2(MECP2):c.1193_1224del; p.Leu398fs
HGVS:
  • NC_000023.11:g.154030642_154030673del
  • NG_007107.3:g.111433_111464del
  • NM_001110792.2:c.1193_1224delMANE SELECT
  • NM_001316337.2:c.878_909del
  • NM_001369391.2:c.878_909del
  • NM_001369392.2:c.878_909del
  • NM_001369393.2:c.878_909del
  • NM_001369394.2:c.878_909del
  • NM_001386137.1:c.488_519del
  • NM_001386138.1:c.488_519del
  • NM_001386139.1:c.488_519del
  • NM_004992.4:c.1157_1188del
  • NP_001104262.1:p.Leu398fs
  • NP_001303266.1:p.Leu293fs
  • NP_001356320.1:p.Leu293fs
  • NP_001356321.1:p.Leu293fs
  • NP_001356322.1:p.Leu293fs
  • NP_001356323.1:p.Leu293fs
  • NP_001373066.1:p.Leu163fs
  • NP_001373067.1:p.Leu163fs
  • NP_001373068.1:p.Leu163fs
  • NP_004983.1:p.Leu386fs
  • LRG_764t1:c.1193_1224del
  • LRG_764t2:c.1157_1188del
  • AJ132917.1:c.1157_1188del32
  • LRG_764:g.111433_111464del
  • LRG_764p1:p.Leu398fs
  • LRG_764p2:p.Leu386fs
  • NC_000023.10:g.153296093_153296124del
  • NC_000023.11:g.154030642_154030673del
  • NG_007107.2:g.111457_111488del
  • NM_004992.3:c.1157_1188del32
  • p.Leu386ArgfsX8
Protein change:
L163fs
Links:
dbSNP: rs267608585
NCBI 1000 Genomes Browser:
rs267608585
Molecular consequence:
  • NM_001110792.2:c.1193_1224del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001316337.2:c.878_909del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001369391.2:c.878_909del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001369392.2:c.878_909del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001369393.2:c.878_909del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001369394.2:c.878_909del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001386137.1:c.488_519del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001386138.1:c.488_519del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001386139.1:c.488_519del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_004992.4:c.1157_1188del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Rett syndrome (RTT)
Synonyms:
Autism, dementia, ataxia, and loss of purposeful hand use; Rett's disorder
Identifiers:
MONDO: MONDO:0010726; MedGen: C0035372; Orphanet: 3095; Orphanet: 778; OMIM: 312750

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000187872RettBASE
no assertion criteria provided
Pathogenic
(Nov 1, 2011)
maternal, unknowncuration

PubMed (7)
[See all records that cite these PMIDs]

SCV001430670Johns Hopkins Genomics, Johns Hopkins University
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 16, 2020)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV001554524Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Mar 16, 2021)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link,

SCV004808974Centre for Population Genomics, CPG
criteria provided, single submitter

(McKnight et al. (Hum Mutat. 2022))
Pathogenic
(Mar 8, 2024)
germlinecuration

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyes9not providednot provided9Nocuration
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation
not providedunknownno1not providednot provided1not providedcuration
not providedmaternalyes2not providednot provided2not providedcuration

Citations

PubMed

Spectrum of MECP2 mutations in Rett syndrome.

Lee SS, Wan M, Francke U.

Brain Dev. 2001 Dec;23 Suppl 1:S138-43.

PubMed [citation]
PMID:
11738860

Influence of mutation type and location on phenotype in 123 patients with Rett syndrome.

Huppke P, Held M, Hanefeld F, Engel W, Laccone F.

Neuropediatrics. 2002 Apr;33(2):63-8.

PubMed [citation]
PMID:
12075485
See all PubMed Citations (12)

Details of each submission

From RettBASE, SCV000187872.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedcuration PubMed (7)
2not provided1not providedNocuration PubMed (7)
3not provided1not providednot providedcuration PubMed (7)
4not provided1not providednot providedcuration PubMed (7)
5not provided1not providednot providedcuration PubMed (7)
6not provided1not providednot providedcuration PubMed (7)
7not provided1not providednot providedcuration PubMed (7)
8not provided1not providednot providedcuration PubMed (7)
9not provided1not providednot providedcuration PubMed (7)
10not provided1not providednot providedcuration PubMed (7)
11not provided1not providedNocuration PubMed (7)
12not provided1not providednot providedcuration PubMed (7)

Description

"Not Rett synd. - Unaffected family member"

Rett syndrome - not certain

Rett syndrome - Preserved speech

"Rett syndrome - Classical"
"Rett syndrome - not certain"
"Rett syndrome - not certain"
"Rett syndrome - not certain"
"Rett syndrome - not certain"
"Rett syndrome - Classical"
"Rett syndrome - Atypical"
"Rett syndrome - atypical"
"Rett syndrome - Not certain"
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownno1not providednot provided1not providednot providednot provided
2unknownyes1bloodnot provided1not providednot providednot provided
3maternalyes1not providednot provided1not providednot providednot provided
4unknownyes1Blood or skinnot provided1not providednot providednot provided
5unknownyes1bloodnot provided1not providednot providednot provided
6unknownyes1bloodnot provided1not providednot providednot provided
7unknownyes1bloodnot provided1not providednot providednot provided
8unknownyes1lymphoblastoid cell linesnot provided1not providednot providednot provided
9maternalyes1not providednot provided1not providednot providednot provided
10unknownyes1Blood or skinnot provided1not providednot providednot provided
11unknownyes1bloodnot provided1not providednot providednot provided
12unknownyes1Bloodnot provided1not providednot providednot provided

From Johns Hopkins Genomics, Johns Hopkins University, SCV001430670.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This MECP2 variant (rs267608585) is absent in a large population dataset and has an entry in ClinVar. This variant has been reported in patients with classic and variant forms of Rett syndrome. This 32-bp deletion results in a frameshift that is predicted to lead to a premature stop codon (PTC) in the last exon of the gene, likely escaping nonsense-mediated decay and resulting in a truncated protein product. This variant is located within a hotspot of deletions in the C-terminus of the MeCP2 protein, which represent ~12% of disease-associated variants in MECP2. We consider it to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001554524.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: MECP2 c.1157_1188del32 (p.Leu386ArgfsX8) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 173875 control chromosomes (gnomAD). c.1157_1188del32 has been reported in the literature in individuals affected with Rett Syndrome (e.g. Zappella_2001, Kammoun_2004, Philippe_2006, Hadzsiev_2011). These data indicate that the variant is likely to be associated with disease. Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Centre for Population Genomics, CPG, SCV004808974.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as pathogenic. At least the following criteria are met: Predicted to result in loss of function, and LOF is a known mechanism of disease (PVS1). Has been observed in at least 5 individuals with phenotypes consistent with MECP2-related disease (PS4). (PubMed: 21160487‚Äö 11738860‚Äö 11746022‚Äö 12075485‚Äö 12180070‚Äö 15173251‚Äö 16473305, ClinVar Variation ID: 143366) This variant is absent from gnomAD (PM2_Supporting).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 12, 2024